Related Experiment Video
Updated: Sep 4, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Dilemma in approach to stroke in sickle cell disease patient: A case report
Lina Okar1, Hadeel Ali Alzoubi2, Safa Shukur Mahmud3
1Department of Medical Education, Hamad Medical Corporation, Doha, Qatar.
Introduction:
Cerebrovascular accidents in sickle cell disease (SCD) patients carry a high socioeconomic impact and represent the most important cause of morbidity, neurological deficits, and impaired quality of life in SCD young population.Patent foramen ovale (PFO) is prevalent in 25% of the general population and it is associated with ischemic stroke in the young population via paradoxical embolism, yet there are no specific guidelines to address how to manage SCD patients with PFO who suffer a stroke.
Patient Concerns And Diagnosis:
Here we present a young SCD patient, aged 24 years, who suffered a stroke in childhood and later was discovered to have a PFO on subsequent echocardiography. The patient has been receiving blood transfusion therapy since 3 years of age.
Interventions And Outcomes:
No treatment was administered to the patient.The intervention that was done was echocardiography with a bubble study to detect PFO.
Conclusion:
Recommendations need to be put in place regarding screening for PFO in patients with SCD, in addition to highlighting issues of whether screening needs to be done in patients who have not developed stroke, and if PFO were to be found, what would be the best management approach and how will prognosis be affected.
More Related Videos
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Atherosclerosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Multiple Allele Traits
Ethical Dilemmas II